Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Bausch + Lomb | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Bausch + Lomb

Daniel M. Wechsler has been appointed corporate vice president and global president of Bausch + Lomb’s Pharmaceuticals business.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Daniel M. Wechsler has been appointed corporate vice president and global president of Bausch + Lomb’s Pharmaceuticals business. Mr. Wechsler assumes the role from Brent Saunders, who has been serving as interim global president of the business unit for the past several months.

“Dan has a strong track record as a senior executive driving high performance in global health care companies,” said Brent Saunders, B+L’s chief executive officer. “His recruitment reflects our continuing progress toward transforming B+L into a high-performance competitor.”

Mr. Wechsler most recently served as head of U.S. Strategy, Commercial Model Innovation and Business Development for Merck, a role he was appointed to following the company’s acquisition of Schering-Plough in 2009. While at Schering-Plough, he was group vice president, Global Business Operations and Selling Excellence, and a member of the global management team. In 2003, Mr. Wechsler joined Pfizer as vice president for its U.S. Specialty Sales organization. He began his career in 1991 with The Upjohn Company (later Pharmacia Corporation), holding a variety of positions.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters